A multicenter single-arm trial of sintilimab in combination with chemotherapy for neoadjuvant treatment of resectable esophageal cancer (SIN-ICE study)

202154 citationsJournal Articlediamond Open Access

Authors

Hongtao Duan · Air Force Medical University

Tianhu Wang · Chongqing Medical University

Zhilin Luo · Chongqing Medical University

Xiaoyuan Wang · Third Affiliated Hospital of Harbin Medical University

Honggang Liu · Air Force Medical University

Liping Tong · Air Force Medical University

Xiaoping Dong

Abstract

Sintilimab in combination with chemotherapy in the neoadjuvant treatment of EC is safe and lead to a high pCR. Therefore, further testing is warranted.

Topics & Keywords

Esophageal Cancer Research and Treatment Gastric Cancer Management and Outcomes Esophageal and GI Pathology

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Annals of Translational Medicine

Volume 9, Issue 22, pp. 1700-1700

DOI: 10.21037/atm-21-6102

Field-Weighted Citation Impact: 10.24